We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

99 hedge funds and large institutions have $747M invested in Autolus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,157% more call options, than puts

Call options by funds: $1.52M | Put options by funds: $21K

580% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 5

189% more capital invested

Capital invested by funds: $258M → $747M (+$489M)

39% more funds holding

Funds holding: 71 → 99 (+28)

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

2.67% more ownership

Funds ownership: 64% → 66.67% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
99
Holders Change
+28
Holders Change %
+39.44%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
21
Reduced
19
Closed
5
Calls
$1.52M
Puts
$21K
Net Calls
+$1.5M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$19.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.6M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.4M
4
PA
Perceptive Advisors
New York
+$6.98M
5
FAM
Fred Alger Management
New York
+$5.17M

Top Sellers

Rank Fund Capital Flow
1
TAM
TFG Asset Management
Cayman Islands
-$15.3M
2
DTC
Deep Track Capital
Connecticut
-$11.9M
3
AC
Armistice Capital
New York
-$11.6M
4
PBA
Paradigm Biocapital Advisors
New York
-$6.85M
5
DCM
DAFNA Capital Management
California
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$2.62M -$572K -150,075 -27%
MCM
27
MAI Capital Management
Ohio
$2.27M -$67K -17,574 -5%
HCA
28
Harbor Capital Advisors
Illinois
$1.99M +$85.6K +22,437 +8%
IC
29
Ikarian Capital
Texas
$1.69M – – –
Two Sigma Investments
30
Two Sigma Investments
New York
$1.66M +$159K +41,561 +19%
ECM
31
ExodusPoint Capital Management
New York
$1.62M -$1.75M -458,994 -65%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$1.43M +$845K +221,489 New
EAM
33
Erste Asset Management
Austria
$1.29M – – –
DCM
34
DAFNA Capital Management
California
$1.23M -$2.81M -737,183 -79%
Morgan Stanley
35
Morgan Stanley
New York
$1.05M +$41.2K +10,796 +7%
Renaissance Technologies
36
Renaissance Technologies
New York
$1.03M -$435K -114,079 -42%
JF
37
Jump Financial
Illinois
$993K +$588K +154,164 New
TD Asset Management
38
TD Asset Management
Ontario, Canada
$871K +$516K +135,300 New
Goldman Sachs
39
Goldman Sachs
New York
$848K +$248K +64,910 +97%
Cetera Investment Advisers
40
Cetera Investment Advisers
Illinois
$847K -$9.54K -2,500 -2%
Victory Capital Management
41
Victory Capital Management
Texas
$768K +$455K +119,230 New
EGI
42
EAM Global Investors
California
$765K +$453K +118,721 New
HP
43
HealthInvest Partners
Sweden
$620K +$367K +96,345 New
Geode Capital Management
44
Geode Capital Management
Massachusetts
$555K – – –
UBS Group
45
UBS Group
Switzerland
$545K +$8.94K +2,345 +3%
RG
46
Rathbones Group
United Kingdom
$446K -$15.3K -4,000 -5%
Jane Street
47
Jane Street
New York
$435K +$204K +53,503 +382%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$422K +$250K +65,527 New
Millennium Management
49
Millennium Management
New York
$391K +$232K +60,730 New
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$341K +$202K +53,004 New
1
2
3 4 5

AUTL Hedge Fund Activity: Q4 2023 in Review

99 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q4 2023, worth a combined $747M — up 189% from $258M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new AUTL positions and 5 closed out — a net gain of 29 holders — while 21 added to existing stakes and 19 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $19.3M. The largest seller was TFG Asset Management, cutting an estimated $15.3M.

  • 99 institutional investors held Autolus Therapeutics (AUTL) as of Q4 2023, up from 71 in Q3 2023.
  • Funds reported $747M of Autolus Therapeutics stock for Q4 2023, up 189% quarter-over-quarter.
  • 34 funds opened new Autolus Therapeutics positions in Q4 2023 and 5 closed out, a net change of +29 holders.
  • The largest Autolus Therapeutics buyer in Q4 2023 was Cormorant Asset Management, an estimated $19.3M added.
  • The largest Autolus Therapeutics seller in Q4 2023 was TFG Asset Management, an estimated $15.3M sold.

Based on aggregated 13F filings for Q4 2023.